| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/27/2001 | US6207193 Transdermal drug delivery system |
| 03/27/2001 | US6207188 Omeprazole sodium salt |
| 03/27/2001 | US6207187 Oxidation resistance of low density lipoproteins |
| 03/27/2001 | US6207180 Intravesical drug delivery |
| 03/27/2001 | US6207179 Mixture of edible oil, thickener, nematocide or parasiticide and cestocidal agent |
| 03/27/2001 | US6207172 Liquids; mixture of water, polyethylene glycol, polyvinylpyrrolidone, buffer and drug |
| 03/27/2001 | US6207158 Parasitic helminth macrophage migration inhibitory factor proteins, nucleic acid molecules, and uses thereof |
| 03/27/2001 | US6207153 Antigen binding polypeptide |
| 03/27/2001 | US6207150 Variants of thymidine kinase, nucleic acids encoding them, and methods of using them |
| 03/27/2001 | US6207142 Compositions containing an antifungal and a cationic agent |
| 03/27/2001 | US6207137 Dental formulation |
| 03/27/2001 | US6207133 Anti-tumoral therapy agent containing a contrast agent |
| 03/27/2001 | US6206847 Medical probe device |
| 03/27/2001 | CA2277722C Water dispersible tablets |
| 03/27/2001 | CA2214399C Soft gelatin capsule with a gelatin shell comprising xanthine derivative |
| 03/27/2001 | CA2198258C Amino acid chelates having improved palatability |
| 03/27/2001 | CA2198217C Use of selegiline to prolong life span |
| 03/27/2001 | CA2148822C Transdermal treatment of cancer with water-insoluble s-camptothecin of the closed lactone ring form |
| 03/27/2001 | CA2140347C Injection and injection kit containing omeprazole and its analogs |
| 03/27/2001 | CA2104196C Methods of combating pneumocystis carinii pneumonia and compounds useful therefor |
| 03/27/2001 | CA2091562C Indole derivatives useful in psychotherapeutics |
| 03/27/2001 | CA2075058C Novel vehicle gas mixtures and their use in medical preparations |
| 03/27/2001 | CA2046916C Methods and compositions for treatment of cancer using oligonucleotides |
| 03/27/2001 | CA2033771C Indolylpropanols, process for their preparation and their use and preparations containing the compounds |
| 03/27/2001 | CA2016985C Dehydrocholecalciferol derivatives |
| 03/27/2001 | CA2007499C Treatment methods and vaccines for stimulating an immune response |
| 03/24/2001 | CA2283374A1 Combination therapies for treating atherosclerosis in mammals |
| 03/23/2001 | CA2309372A1 Use of antibodies against the nef protein for decreasing the chemotaxis which is induced by retrovirus-infected astrocytes |
| 03/22/2001 | WO2001020336A2 SCREENING FOR α2δ-1 SUBUNIT BINDING LIGANDS |
| 03/22/2001 | WO2001020038A1 Novel cell cycle checkpoint genes and proteins encoded thereby |
| 03/22/2001 | WO2001020028A1 Single stranded oligonucleotides, probes, primers and method for detecting spirochetes |
| 03/22/2001 | WO2001020026A2 POLYMORPHISMS IN THE HUMAN hPXR GENE AND THEIR USE IN DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 03/22/2001 | WO2001020025A2 Polymorphisms in the human cyp3a4 and cyp3a7 genes and their use in diagnostic and therapeutic applications |
| 03/22/2001 | WO2001019983A1 Human g-protein coupled receptor |
| 03/22/2001 | WO2001019960A1 Recombinant microorganisms expressing an oligosaccharide receptor mimic |
| 03/22/2001 | WO2001019901A2 Process for making aqueous coated beadlets |
| 03/22/2001 | WO2001019860A2 Proteins associated with cell differentiation |
| 03/22/2001 | WO2001019856A2 Secreted human proteins, polynucleotides encoding them and methods of using the same |
| 03/22/2001 | WO2001019855A2 Pharmaceutical compositions and methods of using secreted frizzled related protein |
| 03/22/2001 | WO2001019840A1 Pesticidal macrolides |
| 03/22/2001 | WO2001019839A1 Glucopyranosides conjugates of 2-(4-hydroxy-phenyl)-1-[4-(2-amin-1-yl-ethoxy)-benzyl]-1h-indol-5-ols |
| 03/22/2001 | WO2001019833A1 Thienoisoxazolyl- and thienylpyrrazolyl-phenoxy substituted propyl derivatives useful as d4 antagonists |
| 03/22/2001 | WO2001019832A2 Thienoisoxazole phenoxy unsubstituted ethyl and propyl derivatives useful as d4 antagonists |
| 03/22/2001 | WO2001019831A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019830A1 MODULATORS OF PROTEIN TYROSINE PHOSPHATASES (PTPases) |
| 03/22/2001 | WO2001019829A2 Pyrazolopyrimidines as therapeutic agents |
| 03/22/2001 | WO2001019828A2 Kinase inhibitors as therapeutic agents |
| 03/22/2001 | WO2001019826A2 Triazolopyrimidine derivatives |
| 03/22/2001 | WO2001019825A1 Pteridinones as kinase inhibitors |
| 03/22/2001 | WO2001019824A2 New active marine alkaloids |
| 03/22/2001 | WO2001019823A2 Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
| 03/22/2001 | WO2001019822A1 Antiviral agents |
| 03/22/2001 | WO2001019821A1 Benzisoxazolyl-, pyridoisoxazolyl- and benzthienyl-phenoxy derivatives useful as d4 antagonists |
| 03/22/2001 | WO2001019819A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019817A2 3-pyrrolidinyloxy-3'-pyridyl ether compounds useful for controlling chemical synaptic transmission |
| 03/22/2001 | WO2001019816A1 Novel spiroheterocyclic compounds useful as reversible inhibitors of cysteine proteases |
| 03/22/2001 | WO2001019815A1 Novel 2-(2-pyridyl)pyrimidine derivatives |
| 03/22/2001 | WO2001019814A2 Carboxylic acids and acylsulfonamides, compositions containing such compounds and methods of treatment |
| 03/22/2001 | WO2001019811A2 N-arymethylthioanilide compounds useful for the inhibition of the replication of hiv |
| 03/22/2001 | WO2001019809A1 Tryptase inhibitors |
| 03/22/2001 | WO2001019808A1 Chemical compounds and compositions and their use as cathepsin s inhibitors |
| 03/22/2001 | WO2001019802A1 Aromatic nitrogenous six-membered ring compounds |
| 03/22/2001 | WO2001019800A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 03/22/2001 | WO2001019798A2 INHIBITORS OF FACTOR Xa |
| 03/22/2001 | WO2001019797A2 HYDROXYALKANOYL AMINOLACTAMS AND RELATED STRUCTURES AS INHIBITORS OF Aβ PROTEIN PRODUCTION |
| 03/22/2001 | WO2001019796A1 Compounds and pharmaceutical compositions as cathepsin s inhibitors |
| 03/22/2001 | WO2001019795A1 Azacycloalkanone serine protease inhibitors |
| 03/22/2001 | WO2001019794A2 Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| 03/22/2001 | WO2001019793A1 4-amino-1-aryl-1,5-dihydro-pyrrole-2-one with anti-convulsive and anxiolytic properties and a method for producing the same |
| 03/22/2001 | WO2001019788A2 BENZAMIDES AND RELATED INHIBITORS OF FACTOR Xa |
| 03/22/2001 | WO2001019784A1 Methods of preparing substituted tetracyclines with transition metal-based chemistries |
| 03/22/2001 | WO2001019780A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO2001019778A1 Novel dicarboxylic acid derivatives with pharmaceutical properties |
| 03/22/2001 | WO2001019776A2 Novel derivatives of dicarboxylic acid having pharmaceutical properties |
| 03/22/2001 | WO2001019770A2 Rxr modulators with improved pharmacologic profile |
| 03/22/2001 | WO2001019542A1 Naturally extracted and synthetic hypoglycemic or hypolipidemic compositions |
| 03/22/2001 | WO2001019430A1 Method and cycler for peritoneal dialysis |
| 03/22/2001 | WO2001019422A1 Polyhydroxyalkanoate compositions for soft tissue repair, augmentation, and viscosupplementation |
| 03/22/2001 | WO2001019413A1 Method and apparatus for producing a sterile fluid |
| 03/22/2001 | WO2001019408A1 Nucleic acids encoding polyepitope polypeptides |
| 03/22/2001 | WO2001019407A2 Taxane prodrugs |
| 03/22/2001 | WO2001019406A2 Amphiphilic prodrugs |
| 03/22/2001 | WO2001019403A1 Liposomal mixture of local anesthetics and manufacturing method thereof |
| 03/22/2001 | WO2001019401A1 Method for producing a tablet made of isomaltulose, isomalt or isolmalt variants |
| 03/22/2001 | WO2001019399A2 Method of potentiating chemotherapy and treating solid tumors |
| 03/22/2001 | WO2001019397A1 Methods and compositions utilizing rad51 |
| 03/22/2001 | WO2001019392A1 Combination of c1-inh and lung surfactant for the treatment of respiratory disorders |
| 03/22/2001 | WO2001019390A1 Combination treatment with il-1ra and diaryl sulphonyl urea compounds |
| 03/22/2001 | WO2001019387A1 Use of mullerian inhibiting substance for treating excess androgen states |
| 03/22/2001 | WO2001019386A2 Composition for stabilizing corneal tissue during or after orthokeratology lens wear |
| 03/22/2001 | WO2001019383A1 Stable carotene-xanthophyll beadlet compositions and methods of use |
| 03/22/2001 | WO2001019378A2 Solid lipid formulations comprising an inhibitor of lipases and a fatty acid ester of polyols |
| 03/22/2001 | WO2001019377A1 Oenothein medicaments |
| 03/22/2001 | WO2001019376A2 METHOD OF INHIBITING NF-λB WITH HEPARIN, FOR TREATING CARDIOVASCULAR DISEASES AND INFLAMMATIONS |
| 03/22/2001 | WO2001019375A1 Inhibiting t-cell proliferation |
| 03/22/2001 | WO2001019374A2 Glucosamine and egg reducing inflammation |
| 03/22/2001 | WO2001019373A2 Methods and compositions for modulating responsiveness to corticosteroids |
| 03/22/2001 | WO2001019372A1 Formulations for parenteral use of estramustine phosphate and amino acids |
| 03/22/2001 | WO2001019371A1 TREATMENT OF MOVEMENT DISORDERS BY ADMINISTRATION OF 5-HYDROXYTRYPTAMINE RECEPTOR/α2 ADRENERGIC RECEPTOR ANTAGONIST COMPOSITIONS |
| 03/22/2001 | WO2001019370A1 Agents for ameliorating erectile dysfunction |